Table 1.
Female Probands % [CI95] | Male Probands % [CI95] | OR [CI95] | |
---|---|---|---|
Lifetime prevalence | 16.4 [13.1, 19.7] | 22.5 [18.2, 26.8] | 1.48 [1.04, 2.09] |
First incidence | |||
0.0 to 13.9 years | 1.9 [0.7, 3.1] | 2.4 [0.8, 4.0] | 1.29 [0.50, 3.36] |
14.0 to 17.9 years | 6.0 [3.8, 8.2] | 7.6 [4.9, 10.3] | 1.30 [0.75, 2.25] |
18.0 to 24.9 years | 7.1 [4.7, 9.5] | 11.6 [8.3, 14.9] | 1.71 [1.06, 2.77] |
25.0 to 30.0 years | 1.4 [0.2, 2.6] | 0.8 [0.0, 1.8] | 0.56 [0.14, 2.26] |
Period prevalence | |||
14.0 to 17.9 years | 7.2 [4.8, 9.6] | 9.9 [6.8, 13.0] | 1.40 [0.85, 2.30] |
18.0 to 24.9 years | 11.4 [8.5, 14.3] | 19.0 [14.9, 23.1] | 1.83 [1.24, 2.71] |
25.0 to 30.0 years | 5.7 [3.5, 7.9] | 11.9 [8.6, 15.2] | 2.25 [1.35, 3.74] |
Point prevalence | |||
T1 (~ age 16) | 1.1 [0.1, 2.1] | 2.0 [0.6, 3.4] | 1.84 [0.58, 5.83] |
T2 (~ age 17) | 0.6 [0.0, 1.4] | 1.8 [0.4, 3.2] | 2.90 [0.72, 11.72] |
T3 (~ age 24) | 2.1 [0.7, 3.5] | 6.7 [4.2, 9.2] | 3.42 [1.59, 7.36] |
T4 (~ age 30) | 2.8 [1.2, 4.4] | 7.3 [4.6, 10.0] | 2.68 [1.36, 5.29] |
Recovery rates | 86.5 [78.7, 94.3] | 77.4 [68.4, 86.4] | 0.54 [0.23, 1.25] |
Recurrence rates for those who recovered | 25.4 [14.8, 36.0] | 30.0 [18.6, 41.4] | 1.26 [0.57, 2.74] |
Note. CI95 = 95% confidence interval. OR = Odds ratio. Bolded ORs are statistically significant. All summary statistics account for sample weighting.